PMID- 20829492 OWN - NLM STAT- MEDLINE DCOM- 20101028 LR - 20211020 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 107 IP - 39 DP - 2010 Sep 28 TI - Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. PG - 17023-8 LID - 10.1073/pnas.1007773107 [doi] AB - Celiac disease (CD) is an enteropathy triggered by the ingestion of gluten proteins from wheat and similar proteins from barley and rye. The inflammatory reaction is controlled by T cells that recognize gluten peptides in the context of human leukocyte antigen (HLA) DQ2 or HLA-DQ8 molecules. The only available treatment for the disease is a lifelong gluten-exclusion diet. We have used RNAi to down-regulate the expression of gliadins in bread wheat. A set of hairpin constructs were designed and expressed in the endosperm of bread wheat. The expression of gliadins was strongly down-regulated in the transgenic lines. Total gluten protein was extracted from transgenic lines and tested for ability to stimulate four different T-cell clones derived from the intestinal lesion of CD patients and specific for the DQ2-alpha-II, DQ2-gamma-VII, DQ8-alpha-I, and DQ8-gamma-I epitopes. For five of the transgenic lines, there was a 1.5-2 log reduction in the amount of the DQ2-alpha-II and DQ2-gamma-VII epitopes and at least 1 log reduction in the amount of the DQ8-alpha-I and DQ8-gamma-I epitopes. Furthermore, transgenic lines were also tested with two T-cell lines that are reactive with omega-gliadin epitopes. The total gluten extracts were unable to elicit T-cell responses for three of the transgenic wheat lines, and there were reduced responses for six of the transgenic lines. This work shows that the down-regulation of gliadins by RNAi can be used to obtain wheat lines with very low levels of toxicity for CD patients. FAU - Gil-Humanes, Javier AU - Gil-Humanes J AD - Instituto de Agricultura Sostenible, Consejo Superior de Investigaciones Cientificas, E-14080 Cordoba, Spain. FAU - Piston, Fernando AU - Piston F FAU - Tollefsen, Stig AU - Tollefsen S FAU - Sollid, Ludvig M AU - Sollid LM FAU - Barro, Francisco AU - Barro F LA - eng SI - GENBANK/HM352557 SI - GENBANK/HM352558 SI - GENBANK/HM352559 PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100909 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (HLA-DQ Antigens) RN - 0 (RNA, Small Interfering) RN - 9007-90-3 (Gliadin) SB - IM MH - Base Sequence MH - Celiac Disease/*immunology MH - Cell Line MH - Epitopes, T-Lymphocyte/*genetics/immunology MH - Gliadin/*genetics/immunology MH - HLA-DQ Antigens/immunology MH - Humans MH - Molecular Sequence Data MH - Nucleic Acid Conformation MH - Plants, Genetically Modified/genetics/*immunology MH - *RNA Interference MH - RNA, Small Interfering/chemistry/genetics MH - T-Lymphocytes/immunology MH - Triticum/genetics/*immunology PMC - PMC2947919 COIS- The authors declare no conflict of interest. EDAT- 2010/09/11 06:00 MHDA- 2010/10/29 06:00 PMCR- 2010/09/09 CRDT- 2010/09/11 06:00 PHST- 2010/09/11 06:00 [entrez] PHST- 2010/09/11 06:00 [pubmed] PHST- 2010/10/29 06:00 [medline] PHST- 2010/09/09 00:00 [pmc-release] AID - 1007773107 [pii] AID - 201007773 [pii] AID - 10.1073/pnas.1007773107 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):17023-8. doi: 10.1073/pnas.1007773107. Epub 2010 Sep 9.